Pay in 4 interest-free payments of $26.25 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
amlexanox prevents OVX-induced bone loss by suppressing osteoclast activity
InChiKey: FWIVDMJALNEADT-SFTDATJTSA-N
Hummersone M
Derbyshire ER
small-molecule HDM2 antagonist with potential antineoplastic activity
Plinabulin Catalog No.:M10736-2 amlexanox prevents OVX-induced bone lossMBRI 001 is a deuterium substituted plinabulin derivative as a potent anti cancer agent. MBRI 001 exhibited better pharmacokinetic characteristics than that of plinabulin. Additionally, its antitumor activity is in a low nanomolar level for a variety of cancer cell lines and high activity against human NCI H460 xenograted in mice intravenous administration. Importantly, continuous administration of MBRI 001 exhibited lower toxicity compared to
US$ 40.00
US$ 18.95
US$ 22.00
US$ 29.99
US$ 26.90
US$ 10.00
US$ 13.00